Tumor growth suppression with novel intra-arterial chemotherapy using epirubicin-entrapped water-in-oil-in-water emulsion in Vivo

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Background/Aim: A mixture of anticancer agents and iodized poppy seed oil (IPSO) has been widely used for intra-arterial chemotherapy of hepatocellular carcinoma. However, the anticancer agents can easily separate from IPSO, so the therapeutic potential is limited. We developed epirubicinentrapped water-in-oil-in-water emulsion (WOW-Epi) using a double-membrane emulsification technique. Materials and Methods: We delivered WOW-Epi through a hepatic arterial injection to VX2 hepatic tumor rabbit model (1.2 mg/kg). Results: VX2 tumor growth was selectively suppressed in the WOW-Epi-treated group compared with the control treated groups. The accumulation of WOW in nearby cancer cells was confirmed via electron-microscopy. Endocytosis seemed to be the mechanism underlying the uptake of WOW. Conclusion: WOW-Epi led to tumour growth suppression in vivo. WOW does not cause toxicity to arterial vessels. WOW-Epi will be hopefully used for repeated intra-arterial chemotherapy to HCC patients in the near future.

Cite

CITATION STYLE

APA

Yanagie, H., Fujino, T., Yanagawa, M., Terao, T., Imagawa, T., Fujihara, M., … Takahashi, H. (2021). Tumor growth suppression with novel intra-arterial chemotherapy using epirubicin-entrapped water-in-oil-in-water emulsion in Vivo. In Vivo, 35(1), 239–248. https://doi.org/10.21873/INVIVO.12252

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free